Zai Lab
Logotype for Zai Lab Limited

Zai Lab (ZLAB) investor relations material

Zai Lab 44th Annual J.P. Morgan Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Zai Lab Limited
44th Annual J.P. Morgan Healthcare Conference summary13 Jan, 2026

Strategic vision and business model

  • Operates a dual-engine model: a profitable commercial business in China and a growing global innovation portfolio.

  • Acts as a gateway for Western biotechs entering China and Chinese innovation expanding globally.

  • Integrated U.S.-China R&D model enables rapid, capital-efficient execution and industry-leading development speed.

  • Maintains a strong balance sheet with $817 million in cash as of September 2025, supporting ongoing investment in R&D.

  • Strategic capital allocation aims for near-term margin expansion and long-term profitability.

Pipeline and R&D highlights

  • Global pipeline focuses on immunology and oncology, emphasizing advanced modalities like ADCs and T-cell engagers.

  • Lead asset Zoci (DLL3 ADC) in phase III for small cell lung cancer, with potential US approval as early as 2028.

  • ZL-1503 (IL-13/31 bispecific) in phase I/1b for atopic dermatitis, with rapid and durable itch suppression in preclinical models.

  • Additional oncology programs (LRRC15 ADC, MUC17 x CD3) to enter or are in clinical trials in 2024.

  • R&D strategy balances internal discovery with selective in-licensing of late preclinical or early clinical assets.

Clinical data and differentiation

  • Zoci shows 68.4% ORR in second-line small cell lung cancer and 80% ORR in brain metastases without prior radiation.

  • Safety profile: only 13% grade 3+ TRAEs, no discontinuations or deaths, supporting use in combination regimens.

  • Phase III trial for Zoci initiated in Q4 2023, targeting 480 patients in real-world settings.

  • IL-13/31 program aims for rapid itch relief and longer duration in atopic dermatitis, targeting a $15–30 billion market.

  • LRRC15 ADC designed for broad-spectrum activity, including sarcomas and epithelial tumors, with phase I starting in 2024.

Zoci's 1L SCLC combo strategy
Timeline for corporate-level profitability
ZL-1503 differentiation in AD market
Financial interplay: China business vs. global R&D?
ZL-1310: How does it overcome SCLC resistance?
Key growth drivers for China commercial business?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Zai Lab earnings date

Logotype for Zai Lab Limited
Q4 202527 Feb, 2026
Zai Lab
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Zai Lab earnings date

Logotype for Zai Lab Limited
Q4 202527 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Zai Lab Limited is a biopharmaceutical company that focuses on developing and commercializing therapies for oncology, autoimmune disorders, infectious diseases, and neurological conditions. The company operates at the intersection of global research and localized healthcare needs, with a strong presence in China and the United States. Zai Lab has a broad portfolio that includes both licensed products and proprietary research-driven candidates, targeting areas of significant unmet medical need. The company is headquartered in Shanghai, China, and its shares are on both the Nasdaq and the Hong Kong Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage